BUTIRRISAN strain Clostridium butyricum CBM588 300mg x 90 tabl
Butirrisan® contains the unique strain Clostridium butyricum CBM588® (isolated in Japan in 1933) – a new generation probiotic, the ONLY one that stimulates the production of butyrate in the colon.
Proven effective in patients with IBS, IBS-D (Irritable Bowel Syndrome with Diarrhea), diverticula, and Helicobacter Pylori.
Irritable bowel syndrome (IBS) includes a group of functional bowel disorders, recurrent abdominal pain associated with defecation, or a change in its rhythm (constipation, diarrhea, alternating constipation with diarrhea), as well as other signs of impaired defecation (abdominal bloating).
Butirrisan® can be used for deficiencies of BUTYRATE and BUTYRATE-PRODUCING BACTERIA, impaired intestinal permeability and motility, pain, diarrhea, bloating and extraintestinal symptoms.
Butirrisan® can be taken alone, or in combination with antibiotics or other probiotics.
After 8 weeks of taking Butirrisan®1+2, it decreases by:
-56% severity of IBS symptoms
-65% incidence of abdominal pain
-85% number of daily diarrhea episodes
1+2Microorganisms 2025,13,1139, Di Pierro, F. Ficuccili
-53% reduction in swelling
-48% reduction in dissatisfaction with bowel habits
-61% reduction in impact on quality of life (QoL)
RDA* - 3 tablets daily, preferably with meals, can be taken at once.
*RDA – Recommended Daily Intake
RDA* - 3 tablets daily, preferably with meals, can be taken at once.
*RDA – Recommended Daily Intake
1 glass bottle contains: 30 tablets
1 tablet contains: ≥4.5×105 CFU/compressed Clostridium butyricum CBM588®
Suitable for both children and adults.
Gluten-free, Suitable for vegan diets. Developed and manufactured by Miyarisan Pharmaceutical Co. (Japan)
Do not exceed the daily dose without consulting your doctor or pharmacist.
Dietary supplements are not a substitute for a varied diet and a healthy lifestyle.
It is not a medicine.
Store at a temperature below 25°C in a dry place, out of the reach of children under 3 years of age.